Burosumab-twza Subcutaneous and Paclitaxel Concentrate Injection
Determining the interaction of Burosumab-twza Subcutaneous and Paclitaxel Concentrate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Paclitaxel Intravenous
- Burosumab-twza Subcutaneous-Paclitaxel Novaplus
- Burosumab-twza Subcutaneous-Paclitaxel protein-bound
- Burosumab-twza Subcutaneous-Paclitaxel protein-bound Intravenous
- Burosumab-twza Subcutaneous-Pacnex
- Burosumab-twza Subcutaneous-Pacnex LP
- Paclitaxel Concentrate Injection-Buspar
- Paclitaxel Concentrate Injection-Buspar Dividose
- Paclitaxel Concentrate Injection-Buspirone
- Paclitaxel Concentrate Injection-Buspirone Hydrochloride
- Paclitaxel Concentrate Injection-Busulfan
- Paclitaxel Concentrate Injection-Busulfan Concentrate Injection